Press Releases September 8, 2026 08:00 AM

MIMEDX to Participate in Upcoming Investor Conferences

MiMedx Group Announces Participation in Two Upcoming Investor Conferences

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
MDXG

MiMedx Group, Inc., a leader in wound care and healing solutions, announced that its senior management will participate in the Cantor Global Healthcare Conference and the Lake Street BIG10 Best Ideas Growth Conference to engage with investors and discuss company developments.

MIMEDX to Participate in Upcoming Investor Conferences
MDXG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • MiMedx is participating in two significant investor conferences to present its growth story.
  • The company focuses on advanced products for chronic and hard-to-heal wounds, burns, and surgical applications.
  • Investor engagement aims to increase visibility and attract interest from healthcare and growth-oriented investors.

MARIETTA, Ga., Sept. 08, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:

Cantor Global Healthcare Conference | New York, NY
Wednesday, September 9, 2026
1:1 sessions

Lake Street BIG10 Best Ideas Growth Conference | New York, NY
Thursday, September 10, 2026
1:1 sessions

Investors interested in meeting with senior management at these events may contact their respective Cantor or Lake Street representative.

About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact:
Matt Notarianni
Investor Relations
470-304-7291
[email protected]


Risks

  • Market reception to the company's growth strategy remains uncertain despite conference participation.
  • The competitive healthcare wound care and regenerative medicine sectors may impact MiMedx's market position.
  • No new product developments or financial updates were provided in this announcement, leaving current operational risks unaddressed.

More from Press Releases

NeOnc' Phase 2 Data Could Put Cancer on the Ropes Sep 8, 2026 Telos Corporation Expands Cyber Risk Management Support for the National Archives and Records Administration Sep 8, 2026 Ex-Google, IBM, Microsoft and HP Research Scientist, Professor Daniel Freedman Joins Quantum X Labs as Distinguished Quantum Scientist Sep 8, 2026 NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System Sep 8, 2026 GlobalFoundries and U.S. Department of Commerce finalize $375M R&D award to advance American quantum leadership Sep 8, 2026